{"\ufeffCOMPARATIVE ANALYSIS OF ARTIFICIAL INTELLIGENCE (AI) AND HUMAN EXPERTISE IN HEART RHYTHM DIAGNOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS\n\nA.K. Mustafa1,2, N.N. Ma3*, A. Mahmud4\n N.H. Nik Ab Rahman1\n1Department of Emergency Medicine, School of Medical Science, Universiti Sains Malaysia\n2Prehospital Care Unit, Department of Emergency Medicine, Hospital Canselor Tuanku Muhriz. University Kebangsaan Malaysia\n3Faculty of Technology and Applied Sciences, Open University Malaysia\n4Faculty of Medicine, Department of Emergency Medicine, Hospital Canselor Tuanku Muhriz. University Kebangsaan Malaysia.\n\n*Corresponding Author's Email: kindoctormd31@gmail.com\n\nArticle History: Received October 2, 2024": null, " Revised November 14, 2024": null, " \nAccepted November 17, 2024\n\nABSTRACT: Arrhythmias, characterized by irregular, fast, or slow heartbeats, can lead to severe complications if not detected and managed promptly. Artificial intelligence (AI) has emerged as a promising tool for analysing cardiac rhythm recordings, potentially improving the accuracy and efficiency of arrhythmia diagnosis. This systematic review and meta-analysis aimed to compare the accuracy of AI and human analysis in interpreting cardiac rhythm recordings and to explore the potential of AI to enhance diagnoses in pre-hospital care settings. A comprehensive search was conducted in multiple electronic databases, including PubMed, Scopus, Web of Science, IEEE Xplore, and the Cochrane Library, to identify studies comparing the accuracy of AI and human analysis in interpreting cardiac rhythm recordings. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The quality of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. A random-effects model was used for meta-analysis, and subgroup analyses were performed based on AI algorithm type and data acquisition method. Twenty-two studies were included in the qualitative synthesis, and 18 were suitable for meta-analysis. The pooled sensitivity, specificity, and area under the receiver operating characteristic curve (AUC-ROC) were consistently higher for AI compared to human analysis. Deep learning algorithms demonstrated superior accuracy compared to machine learning algorithms. Studies using electrocardiogram (ECG) as the data acquisition method showed higher pooled AUC-ROC compared to those using Holter monitors. The findings suggested that AI algorithms, particularly deep learning methods, have higher accuracy in interpreting cardiac rhythm recordings compared to human analysis. AI-based diagnostic tools have the potential to improve the early detection and management of arrhythmias in pre-hospital care settings. However, further research is needed to validate these results in real-world clinical settings, address the limitations of current studies, and explore the long-term impact of AI on patient outcomes and healthcare delivery.\n\nKEYWORDS: Artificial intelligence, cardiac rhythm, electrocardiogram, accuracy, systematic review, meta-analysis\n\n    1.0 INTRODUCTION\nArrhythmias, frequently used to describe cardiac rhythm disorders, are conditions where the electrical impulses that regulate the heartbeat malfunction, resulting in an irregular, fast, or slow heartbeat [1]. The severity and nature of these disorders can determine whether they are life-threatening or benign. Commonly encountered arrhythmias include atrial fibrillation, characterized by rapid and irregular beating of the atrial chambers, and ventricular tachycardia, which can lead to more severe complications such as ventricular fibrillation.\nThe ventricles quiver ineffectively in ventricular fibrillation due to rapid and erratic electrical impulses. Symptoms of arrhythmias may include chest pain, shortness of breath, dizziness, syncope, and palpitations. The aetiology of arrhythmias can be multifactorial, encompassing genetic predispositions, structural cardiac disease, electrolyte imbalances, and comorbid conditions such as hypertension and diabetes. Early detection and appropriate management of arrhythmias are essential to prevent adverse outcomes and enhance patients' quality of life [2].\nAccurate diagnosis and monitoring of heart rhythm problems are crucial to avoid significant consequences and improve patient outcomes [3]. Misdiagnosis or delayed diagnosis can lead to poor treatment, stroke, heart failure, or sudden cardiac death. Continuous monitoring with Holter monitors, event recorders, and implantable loop recorders detects intermittent and asymptomatic arrhythmias, providing valuable data for treatment decisions.\nTechnological advances in diagnostic equipment and methodologies, including artificial intelligence, have improved arrhythmia identification and management. AI technologies, including machine learning and deep learning algorithms, have the capability to swiftly and accurately analyse intricate medical data, uncovering patterns and abnormalities that may pose challenges for human clinicians [4]. This skill is particularly advantageous in fields like radiology, pathology, and cardiology, where precise and prompt data analysis is essential. \nAI systems are being incorporated into diagnostic instruments with the potential to decrease diagnostic mistakes, enhance patient outcomes, and optimize healthcare resources. The advancement of AI is anticipated to lead to an expansion of its use in personalized medicine, early disease detection, and continuous health monitoring, transforming the field of medicine [5]. \nDisorders of the heart's rhythm, or arrhythmias, include irregular, rapid, or slow heartbeats and include ailments such as bradyarrhythmia, ventricular tachycardia, and atrial fibrillation [6]. Depending on the individual, symptoms can be mild or severe. Medication, catheter ablation, and pacemakers are all part of the management plan. The ability to better diagnose and treat heart conditions depends on electrophysiology and cardiac imaging developments.\nHeart rhythm analysis traditionally depends on the proficiency of cardiologists and electrophysiologists who utilize tools like electrocardiograms (ECGs) and Holter monitors to identify and track arrhythmias. These instruments capture the heart's electrical signals, which professionals then analyse to detect abnormalities. Although these methods are successful, they can be time-consuming and prone to human error, emphasizing the need for more efficient diagnostic approaches [7].\nIn clinical practice, an accurate diagnosis is critical for directing treatment appropriately, decreasing morbidity, and improving patient outcomes [8]. Ineffective therapy, higher healthcare expenses, and increased patient morbidity and mortality rates might result from misdiagnosis or delayed diagnosis. Heart failure (HF) diagnosis was one area where the CORE Needs Assessment Survey found major gaps in clinical practice. Echocardiography and electrocardiograms (ECGs) are vital diagnostic tools, yet many doctors overlook important warning signs of heart failure and fail to use them. Delays or omissions in diagnosis may occur because primary care physicians (PCPs) and nurses lack confidence when interpreting these tests. Despite increased diagnostic self-assurance, cardiologists continued to confront obstacles, most notably in the diagnosis of HF with maintained ejection fraction.\nAI has increasingly become a part of healthcare, transforming diagnostic processes. Over multiple decades, notable progress has been made in developing machine learning and deep learning algorithms. These technologies play a crucial role in analysing cardiac rhythm and efficiently handling large data volumes with unmatched speed and precision. AI systems are engineered to recognize and pinpoint patterns and irregularities in heart rhythm recordings that may challenge human clinicians [9].\nThe application of AI in healthcare entails programming computers to perform tasks typically performed by humans, such as analysing data, recognizing patterns, and making decisions. The goal of artificial intelligence (AI) in healthcare is to improve efficiency and effectiveness in various areas, including diagnosis, treatment planning, robotic surgery, personalized medicine, and therapy recommendations [10].\nMedical diagnostics has advanced dramatically due to the development and application of artificial intelligence (AI), which has improved diagnostic efficiency and accuracy [11]. Artificial intelligence (AI) systems, in particular convolutional neural networks (CNN), are highly skilled in processing complex medical pictures, including ultrasound, CT, MRI, and X-ray images. CNN models have proven to perform better with greater accuracy, sensitivity, and specificity than conventional diagnostic techniques. For instance, CNN's accuracy of 94% in X-ray image analysis beat that of 88% with conventional techniques, demonstrating its potency in detecting abnormal characteristics. Furthermore, CNN achieved 94% sensitivity in MRI analysis, greatly enhancing the detection of actual clinical situations and decreasing misdiagnosis. This development is essential for prompt and precise medical diagnosis, which in turn improves patient outcomes. Nonetheless, interpretability issues arising from the intricacy of AI models require efforts to make AI decision-making procedures transparent to healthcare providers. The use of AI in medical diagnostics is a paradigm shift that has significant advantages for clinical practice but also raises ethical and practical issues that must be carefully considered.\nMachine learning and deep learning are two of the most important technologies in artificial intelligence (AI). They are changing many fields by letting computers learn from data. Creating algorithms for machine learning enables computers learn from data and make choices based on that data. On the other hand, deep learning is a subset of machine learning that uses neural networks to mimic how the human brain works. It is very good at tasks like speech and picture recognition. These technologies look at very large sets of data to make predictions and choices more accurate and faster. Convolutional neural networks (CNNs), which are part of deep learning, are very good at handling image data, finding complicated patterns, and guessing what will happen. Deep learning is better at solving difficult problems with unstructured data, while machine learning is better at working with structured data [12].\nAI models greatly improved cardiac rhythm problem diagnosis. Using electrocardiogram (ECG) data, neural network (NN) and convolutional neural network (CNN) models were built to detect arrhythmias, including atrial fibrillation (AF), with an accuracy of over 99%. AI models in smartwatches also demonstrated high sensitivity in AF detection, improving diagnostic precision and accessibility in clinical settings [13].\nSeveral studies had compared the accuracy of AI and human analysis in cardiac rhythm recordings [14,15]. Research indicated that AI could detect arrhythmias with consistency and speed comparable to that of a cardiologist. However, gaps remained in the literature regarding the long-term dependability of AI and its incorporation into clinical practice. More research was needed to close these gaps and confirm AI's efficacy in various therapeutic contexts and patient populations.\nAlmansouri et al. (2024) studied the diagnostic performance of AI models and human specialists in diagnosing heart rhythm abnormalities, particularly atrial fibrillation. When compared to conventional techniques, the AI-ECG models performed better in terms of sensitivity (100%) and specificity (97%). The study demonstrated how AI could improve diagnosis efficiency and accuracy for heart rhythm problems, representing a major improvement over human expertise [16].\n        1.1 Artificial Intelligence Methods in Cardiac Rhythm Analysis\nThe development of artificial intelligence methods in cardiac rhythm analysis has evolved significantly over the past decade. Traditional machine learning algorithms initially demonstrated significant potential in heart rhythm analysis by implementing pattern recognition for ECG interpretation [6]. These early systems successfully classified basic arrhythmia types using structured data and predefined features. However, while achieving moderate accuracy in preliminary studies, these systems were limited by their reliance on manual feature extraction.\nRecent developments in deep learning, particularly with neural networks, have revolutionized cardiac analysis. Convolutional Neural Networks (CNNs) have shown exceptional capabilities in processing ECG data [12]. These deep learning models can automatically extract relevant features and demonstrate superior performance in complex pattern recognition, with significantly improved real-time analysis capabilities.\nFurther supporting this advancement, Shu et al. (2021) demonstrated that neural network models achieved remarkable accuracy exceeding 99% in arrhythmia detection. Their research showed that CNN models were particularly effective in atrial fibrillation detection, with deep learning models demonstrating superior performance in handling noise and variations in signal data. Integrating these technologies with smartwatches has notably improved diagnostic accessibility in various clinical settings [13]. \n        1.2 Clinical Applications and Performance Analysis\nRecent meta-analyses and systematic reviews have provided robust evidence supporting AI's effectiveness in clinical settings. Manetas-Stavrakakis et al. (2023) conducted a comprehensive review that revealed consistently higher accuracy rates for AI compared to human interpretation. Their research documented improved detection of paroxysmal arrhythmias and enhanced capability in identifying subtle ECG changes while significantly reducing time to diagnosis [14].\nIn a groundbreaking study, Almansouri et al. (2024) reported exceptional performance metrics for AI-ECG models, achieving 100% sensitivity in atrial fibrillation detection and 97% specificity in rhythm analysis. These results represented a significant improvement over conventional diagnostic methods, with consistent performance demonstrated across diverse patient populations [16].\nThe practical implementation of AI systems in healthcare settings has shown promising results. Kumar and Alen (2021) documented successful AI integration across various healthcare contexts, from emergency departments to primary care settings. Their research highlighted the versatility of AI applications in both acute and chronic care management, demonstrating particular success in remote monitoring systems and telemedicine platforms [10].\n        1.3 Validation and Clinical Integration\nClinical validation studies have provided crucial insights into AI's real-world performance. Ng et al. (2021) conducted extensive research showing that AI systems consistently matched cardiologist-level accuracy in rhythm interpretation. Their findings demonstrated particular promise in real-time monitoring applications, though they emphasized the need for further validation across diverse clinical settings [14].\nThe integration of AI systems into clinical practice has faced several challenges, highlighting the importance of standardized data formats and seamless integration with existing healthcare systems [9]. They also emphasized the critical need for ongoing validation processes and comprehensive training programs for healthcare providers to ensure optimal system utilization.\n        1.4 Future directions\nThe future of AI in cardiac rhythm analysis shows tremendous promise. Nagarajan et al. (2021) outlined several emerging trends, including the development of increasingly sophisticated neural networks and enhanced integration with wearable technology. Their research emphasized the importance of improving the interpretability of AI decisions, making these systems more transparent and trustworthy for clinical use [4].\nWang et al. (2021) further expanded on future developments, highlighting the potential for comprehensive integration with electronic health records and enhanced decision support systems. Their work emphasized the growing importance of patient-centered monitoring solutions and the need for ongoing validation studies to ensure clinical effectiveness [3].\nThis thematic review demonstrates the significant progress in AI applications for cardiac rhythm analysis, particularly highlighting the transition from basic machine learning to sophisticated deep learning systems. The evidence consistently suggests superior performance of AI in rhythm interpretation, while also acknowledging the challenges and requirements for successful clinical implementation. Current trends indicate continued advancement in both technology and clinical applications, with a focused emphasis on improved accuracy, accessibility, and integration with existing healthcare systems.\n\n    2.0 METHODOLOGY\n        2.1 Research design\nThis study utilized a systematic literature review (SLR) technique that followed PRISMA criteria to assess the accuracy of AI and human analysis in interpreting heart rhythm data. The PRISMA framework enabled a clear and reproducible procedure, reducing bias and increasing the trustworthiness of the findings [17].\n        2.2 Search strategy\nA comprehensive search strategy was created in collaboration with a medical librarian to identify relevant studies from electronic databases such as PubMed, Scopus, Web of Science, IEEE Xplore, and the Cochrane Library. The search phrases included keywords and Medical Subject Headings (MeSH) for AI, machine learning, deep learning, heart rhythm, arrhythmia, ECG, accuracy, and human analysis. The entire search method for each database was described and provided in the supplemental materials. The search was limited to articles published in English between January 1, 2015, and December 31, 2023, to ensure the inclusion of the most recent and relevant studies.\n        2.3 Inclusion and exclusion criteria\nStudies were included if they:\n    \u2022 Assessed the precision of AI and human analysis in interpreting heart rhythm recordings\n    \u2022 Used ECG or other cardiac monitoring equipment to gather data\n    \u2022 Presented quantitative accuracy statistics, such as sensitivity, specificity, positive predictive value, negative predictive value, or AUC-ROC.\n    \u2022 This study included adult patients who were 18 years or older and had suspected or confirmed arrhythmias. \n    \u2022 The findings of this study were published in peer-reviewed journals or conference proceedings.\nStudies were excluded if they:\n    \u2022 Examined either AI or human analysis exclusively, without making any comparisons. \n    \u2022 Did not provide any quantitative metrics of accuracy. \n    \u2022 Only involved patients who were under 18 years old.\n    \u2022 Case reports, editorials, letters to the editor, and review pieces were included. Pieces that were not published in English were excluded.\n        2.4 Study selection and data extraction\nThe procedure of selecting studies adhered to the PRISMA flow diagram. Two autonomous reviewers evaluated the titles and abstracts of the discovered studies using reference management software (such as Covidence), according to specific inclusion and exclusion criteria. Complete papers were obtained for research that satisfied the requirements or necessitated additional assessment. Conflicting opinions among reviewers were handled by engaging in dialogue or seeking input from a third reviewer. The rationales for excluding studies throughout the full-text evaluation were documented and displayed in the PRISMA flow diagram.\nData were extracted utilizing a standardized form that had been tested on a subset of studies to guarantee uniformity and thoroughness. The extracted data encompassed study parameters, participant characteristics, AI algorithms utilized, data gathering techniques, reference standards, and accuracy measures. Two reviewers autonomously extracted the data, resolving any inconsistencies through dialogue or by seeking input from a third reviewer.\n        2.5 Quality assessment\nThe QUADAS-2 tool was used to assess the quality of the included studies. This instrument examined the risk of bias and applicability concerns in four domains: patient selection, index test, reference standard, and flow and timing. Two reviewers evaluated the quality of the research separately, resolving any disputes through conversation or by seeking input from a third reviewer. The findings were showcased in a concise table and written description, emphasizing the positive aspects and drawbacks of the included research.\n        2.6 Data synthesis and analysis\nThe extracted data were combined using both qualitative and quantitative methodologies. A narrative synthesis provided a concise overview of the main discoveries, methodological elements, and research constraints that were included. This synthesis was structured according to the type of AI algorithm used, the manner of data gathering, and the specific group of patients involved. If the available data allowed, a meta-analysis was conducted using a random-effects model to determine the combined accuracy metrics of AI and human analysis in interpreting heart rhythm recordings. The variability among studies was evaluated using the I\u00b2 statistic and examined through subgroup analyses. Funnel plots and Egger's test were used to evaluate publication bias, but only if the meta-analysis included a minimum of ten studies.\nThe analysis of extracted data employed a comprehensive approach combining both qualitative and quantitative methodologies to ensure a thorough evaluation of the evidence. The qualitative component involved a systematic narrative synthesis structured around three primary dimensions: AI algorithm types, data acquisition methods, and patient populations. This synthesis examined the various machine learning and deep learning approaches employed across studies, including support vector machines, random forests, decision trees, and neural networks, along with their specific architectural features and parameters. The analysis also considered the diverse methods of data acquisition, ranging from standard 12-lead ECG recordings to Holter monitoring and wearable device data, while evaluating the quality and standardization of data collection procedures. Patient population characteristics, including demographics, clinical conditions, and treatment outcomes, were thoroughly examined to understand the breadth and applicability of the findings.\nFor the quantitative analysis, we employed a random-effects model, a choice driven by the expected heterogeneity between studies due to variations in AI algorithms, patient populations, healthcare settings, and data collection methods. This model was particularly appropriate as it accounts for both within-study and between-study variance, recognizing that the true effect size likely varies across studies due to differences in sample sizes, technological implementations, clinical contexts, and healthcare provider expertise levels.\nThe statistical analysis incorporated several sophisticated methods to ensure robust results. Heterogeneity was assessed using the I\u00b2 statistic, which quantifies the percentage of variation across studies due to true heterogeneity rather than chance. Values were interpreted on a scale where 0-25% indicated low heterogeneity, 26-50% moderate heterogeneity, and values above 50% suggested substantial heterogeneity. The significance of heterogeneity was further evaluated using the Chi-squared test. Comprehensive subgroup analyses were conducted separately for different AI algorithms, data acquisition methods, patient populations, and clinical settings, helping to identify potential sources of heterogeneity and evaluate the consistency of findings across different contexts.\nPublication bias assessment was particularly rigorous for meta-analyses including ten or more studies. This assessment utilized funnel plots for visual evaluation of asymmetry, complemented by Egger's test for statistical verification of publication bias. Trim-and-fill analyses were employed to assess the potential impact of missing studies, while sensitivity analyses evaluated the robustness of the findings. Effect sizes were calculated using bivariate random-effects models for pooled sensitivity and specificity, while DerSimonian and Laird random-effects models were used for pooling AUC-ROC values. All effect sizes were reported with 95% confidence intervals, and forest plots were generated to visualize the distribution of effects across studies. Additionally, 95% prediction intervals were calculated to estimate the range of true effects in similar future studies, accounting for both the uncertainty in the mean effect and between-study heterogeneity.\nQuality assurance measures were implemented throughout the analysis process. All statistical analyses were performed using comprehensive statistical software packages, with calculations independently verified by multiple researchers. Sensitivity analyses were conducted to assess the impact of potential outliers, and results were cross-validated using different statistical approaches where applicable. The analysis and reporting adhered strictly to established guidelines, including PRISMA for systematic reviews and meta-analyses, STARD for diagnostic accuracy studies, and TRIPOD for prediction model studies.\nThis comprehensive approach to data synthesis and analysis ensured a robust evaluation of the evidence while appropriately considering heterogeneity and potential biases. The resulting findings provided a strong foundation for evaluating the comparative accuracy of AI and human analysis in interpreting cardiac rhythm recordings. The analysis acknowledged and accounted for various sources of variation and potential bias in the included studies, thereby strengthening the reliability and applicability of the conclusions for clinical practice. This methodological rigor enhances the value of our findings for informing future research and clinical applications in the field of AI-assisted cardiac rhythm interpretation.\n        2.7 Data synthesis and analysis\nThe analysis of extracted data employed a comprehensive and multifaceted approach, combining both qualitative and quantitative methodologies to ensure thorough evaluation of the evidence. This dual methodology approach was essential to capture both the nuanced aspects of AI implementation in cardiac rhythm analysis and the statistical significance of the findings. The synthesis process was systematically planned and executed according to pre-established protocols to minimize potential bias and ensure the reproducibility of results.\nThe qualitative component involved a systematic narrative synthesis structured around three primary dimensions: AI algorithm types, data acquisition methods, and patient populations. This synthesis examined the various machine learning and deep learning approaches employed across studies, including support vector machines, random forests, decision trees, and neural networks, along with their specific architectural features and parameters. Particular attention was paid to the evolution of AI algorithms over time, from simple machine learning models to sophisticated deep learning architectures. The technical specifications of each algorithm were carefully documented, including training methodologies, validation procedures, and performance optimization techniques. The analysis extensively evaluated how different AI architectures handled various types of cardiac rhythm abnormalities, their ability to detect subtle patterns and their performance in complex clinical scenarios.\nThe analysis of data acquisition methods was equally comprehensive, ranging from standard 12-lead ECG recordings to Holter monitoring and wearable device data. This included a detailed examination of signal processing techniques, noise reduction methods, and data standardization procedures. The quality assessment of data collection methods considered factors such as recording duration, sampling frequency, signal-to-noise ratio, and adherence to established recording protocols. Special attention was given to validating novel data collection methods, particularly in the context of emerging wearable technologies and mobile health applications. The evaluation included data completeness analysis, timestamp information accuracy, and handling missing or corrupted data segments.\nPatient population characteristics were meticulously analyzed, encompassing demographics, clinical conditions, comorbidities, and treatment outcomes. This included detailed stratification of patient groups based on age, gender, ethnicity, and clinical risk factors. The analysis considered both acute and chronic cardiac conditions, varying levels of disease severity, and the presence of confounding factors. Treatment outcomes were evaluated across different timeframes, including immediate diagnostic accuracy, short-term clinical decision-making impact, and long-term patient outcomes.\nFor the quantitative analysis, we employed a sophisticated random-effects model, a choice driven by the expected heterogeneity between studies due to variations in AI algorithms, patient populations, healthcare settings, and data collection methods. This model was selected after careful consideration of various meta-analytic approaches and was deemed most appropriate for handling the complex, multi-dimensional nature of the data. The model specifically accounted for both within-study and between-study variance, recognizing that the true effect size likely varies across studies due to differences in sample sizes, technological implementations, clinical contexts, and healthcare provider expertise levels. The model implementation included rigorous sensitivity analyses to assess the impact of model assumptions and parameter choices.\nThe statistical analysis framework incorporated multiple sophisticated methods to ensure robust results. Heterogeneity assessment using the I\u00b2 statistic was complemented by additional measures, including Cochran's Q test and \u03c4\u00b2 estimation. The interpretation of heterogeneity considered both statistical significance and clinical relevance, with values interpreted on a comprehensive scale where 0-25% indicated low heterogeneity, 26-50% moderate heterogeneity, and values above 50% suggested substantial heterogeneity. Multiple subgroup analyses were conducted using hierarchical models to account for the nested structure of the data, considering variations in AI algorithms, data acquisition methods, patient populations, and clinical settings.\nPublication bias assessment employed a multi-level approach for meta-analyses including ten or more studies. Funnel plot analysis was enhanced with contour-enhanced funnel plots to better distinguish between publication bias and other sources of asymmetry. Egger's test was supplemented with additional statistical methods including Begg's test and the trim-and-fill method. The impact of potential missing studies was evaluated through comprehensive sensitivity analyses, including leave-one-out analyses and cumulative meta-analysis approaches. Effect sizes were calculated using sophisticated statistical models, including bivariate random-effects models for diagnostic accuracy measures and DerSimonian and Laird random-effects models for continuous outcomes. All effect sizes were reported with both 95% confidence intervals and prediction intervals, providing a more complete picture of the expected range of effects in future studies.\nQuality assurance measures were implemented throughout the analysis, following a rigorous protocol with multiple validation steps. All statistical analyses were performed using state-of-the-art statistical software packages, with calculations independently verified by multiple researchers using different software platforms to ensure consistency. Extensive sensitivity analyses were conducted to assess the impact of potential outliers, influential cases, and varying analytical approaches. The analysis adhered strictly to established guidelines, including PRISMA for systematic reviews and meta-analyses, STARD for diagnostic accuracy studies, and TRIPOD for prediction model studies, with detailed documentation of any deviations from these guidelines and their justification.\nThis comprehensive and methodologically rigorous approach to data synthesis and analysis ensured a thorough evaluation of the evidence while appropriately considering all sources of variation and potential bias. The resulting findings provided a strong foundation for evaluating the comparative accuracy of AI and human analysis in interpreting cardiac rhythm recordings. The careful attention to methodological detail and comprehensive documentation of all analytical decisions enhances the reproducibility and reliability of our findings, making them particularly valuable for informing future research and clinical applications in the field of AI-assisted cardiac rhythm interpretation.\n        2.8 Potential implications and future directions\nThe results of this SLR provided a comprehensive picture of how well AI and human analysis compared in reading cardiac rhythm recordings. This had important implications for both clinical practice and research. The findings could aid in the development and implementation of AI-based diagnostic tools in pre-hospital care situations, potentially facilitating the early detection and treatment of arrhythmias. Identifying gaps in the current research helped guide future studies, such as the need for prospective studies with larger sample sizes, testing AI in a variety of patient populations and clinical settings, and evaluating AI's long-term dependability and its role in clinical decision-making. The SLR also highlighted the importance of establishing standard reporting guidelines for studies comparing AI and human analysis in medical diagnostics, enhancing transparency, reproducibility, and comparability in future research.\n\n    3.0 RESULTS AND DISCUSSION\n        3.1 Study selection\nThe comprehensive literature search identified 1,752 records from electronic databases and 18 additional records from other sources. After removing duplicates, the titles and abstracts of 1,412 records were screened. Out of these, 1,298 records were excluded for not meeting the inclusion criteria. The remaining 114 full-text articles were assessed for eligibility, and 92 were excluded for various reasons. Ultimately, 22 studies were included in the qualitative summary, and 18 were deemed suitable for meta-analysis.\nOur comprehensive literature search yielded a significant body of evidence, with a total of 1,752 records identified from electronic databases and 18 additional records from other sources. After a thorough screening process and removal of 340 duplicates, 1,412 records were evaluated for eligibility. The initial screening led to the exclusion of 1,298 records based on our predefined criteria. Among the remaining 114 full-text articles assessed in detail, 92 were excluded for various reasons: 25 focused solely on AI or human analysis without comparison, 20 lacked quantitative accuracy measures, 10 included only pediatric patients, 15 were case reports or review articles, and 22 were not published in English. This rigorous selection process resulted in 22 studies meeting all inclusion criteria for qualitative synthesis, with 18 providing sufficient data for meta-analysis.\nThe temporal and geographical distribution of the included studies revealed significant patterns in research development. The studies spanned from 2015 to 2023, with a notable concentration (n ": null}